NIH-funded research R01 grant

Improving MRI scans to better visualize brain metabolism in tumors

Official title: Time-efficient MRI and deuterium metabolic imaging (DMI) through parallel signal acquisition

Funded at Yale University · NIH-11110364 · Data updated 2026-11-12

This study is testing a new way to take pictures of the brain that helps doctors see how brain tumors are using energy, which could make it easier to understand and treat these tumors while keeping the process quick and comfortable for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startJune 8, 2024
Project endMarch 31, 2028
Funding year2025
Award (this year)$426,782
NIH project number5R01EB034730-02
Project IDNIH-11110364 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with high-grade brain tumors who require imaging for treatment evaluation.

Less likely to help

Patients with low-grade brain tumors or those without brain tumors may not benefit from this research.

What this research studies

This research focuses on a new imaging technique called deuterium metabolic imaging (DMI) that allows for non-invasive mapping of metabolism in the brain. By combining DMI with standard MRI scans, the researchers aim to provide detailed insights into the metabolic processes of high-grade brain tumors, which can reveal abnormal metabolic activity known as the 'Warburg effect.' The approach is designed to be efficient, minimizing scan times while maximizing the information obtained, which could enhance patient comfort and compliance during imaging procedures.

Why it matters

Potential benefit: If successful, this research could lead to improved detection and characterization of brain tumors, allowing for better treatment planning and patient outcomes.

How similar studies have gone: Previous research has shown promise with metabolic imaging techniques, but DMI represents a novel approach that has not yet been widely tested in clinical settings.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: De Graaf, Robin a — Yale University
  • Study coordinator: De Graaf, Robin a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.